SFZN.SW Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 18:30):

Stats
Dzisiejszy wolumen	3 412.00
Średni wolumen	6 590.00
Kapitalizacja rynkowa	3.70B
EPS	CHF0 ( 2024-02-19 )
Last Dividend	CHF0 ( N/A )
Next Dividend	CHF0 ( N/A )
P/E	32.90
ATR14	CHF1.142 (0.13%)

Wolumen Korelacja

Długi: 0.11 (neutral)

Krótki: 0.23 (neutral)

Signal:(26.52) Neutral

Siegfried Holding AG Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Siegfried Holding AG Korelacja - Waluta/Towar

-0.72
( moderate negative )

-0.62
( weak negative )

-0.02
( neutral )

-0.69
( moderate negative )

0.61
( weak )

Siegfried Holding AG Finanse

Annual	2023
Przychody:	CHF1.27B
Zysk brutto:	CHF320.41M (25.20 %)
EPS:	CHF26.61

FY	2023
Przychody:	CHF1.27B
Zysk brutto:	CHF320.41M (25.20 %)
EPS:	CHF26.61

FY	2022
Przychody:	CHF1.23B
Zysk brutto:	CHF318.69M (25.92 %)
EPS:	CHF37.07

FY	2021
Przychody:	CHF1.10B
Zysk brutto:	CHF239.57M (21.73 %)
EPS:	CHF22.73

Financial Reports:

No articles found.

Siegfried Holding AG

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.